Imprimis Pharmaceuticals Announces First Quarter 2018 Results
PR Newswire (press release)-17 hours ago
The company's flexible business model allows a drug to be compounded or developed as an FDA-approved product through one of its subsidiaries or ...
No comments:
Post a Comment